Saint-Grégoire, France

Michel Jean Martin

This inventor holds 2 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Smithkline Beecham Farmaceutici. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Jean Martin. Retrieved from https://idiyas.com/inventor/michel-jean-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • St. Gregoire, FR (1999)
  • St Gregoire, FR (2000)

Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michel Jean Martin: A Pioneer in Pharmaceutical Innovations

Introduction: Michel Jean Martin, hailing from St. Gregoire, France, is an esteemed inventor known for his significant contributions to the field of pharmaceuticals. With two patents to his name, Martin has focused on developing compounds that hold promise in treating various medical conditions.

Latest Patents: Among his most recent patents are "Heteroaromatic pentadienoic acid derivatives" which have been identified as useful inhibitors, and "Nitro-benzamides" that are developed as potential anti-arrhythmic agents. These innovations reflect Martin's commitment to enhancing healthcare through his inventive prowess.

Career Highlights: Martin's professional journey includes notable tenures at respected organizations such as SmithKline Beecham Corporation and SmithKline Beecham Farmaceutici. His work at these companies has been instrumental in advancing pharmaceutical research and development, laying the groundwork for significant medical breakthroughs.

Collaborations: Throughout his career, Martin has collaborated with distinguished colleagues, including Guy Marguerite Nadler and Carlo Farina. These partnerships have fostered an environment of innovation, enabling the exchange of ideas and techniques that have propelled their projects forward.

Conclusion: Michel Jean Martin's contributions as an inventor in the pharmaceutical industry illustrate the impact of dedicated research and innovation. With his patents leading the way for new treatments, Martin continues to be a significant figure in the realm of healthcare solutions, inspiring future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…